FDA Approves BELBUCA — BioDelivery Sciences International Inc
BioDelivery Sciences International Inc. announced the FDA approval of BELBUCA, a buccal film intended for the management of moderate to severe chronic pain that positions the company to compete directly with established opioid delivery systems and transdermal patch manufacturers.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day